Pages that link to "Item:Q5222223"
From MaRDI portal
The following pages link to Model-free approach to quantifying the proportion of treatment effect explained by a surrogate marker (Q5222223):
Displaying 11 items.
- A shrinkage approach for estimating a treatment effect using intermediate biomarker data in clinical trials (Q2893404) (← links)
- A Measure of the Proportion of Treatment Effect Explained by a Surrogate Marker (Q3079026) (← links)
- Evaluation of longitudinal surrogate markers (Q6050955) (← links)
- Evaluating multiple surrogate markers with censored data (Q6055488) (← links)
- Quantifying direct and indirect effect for longitudinal mediator and survival outcome using joint modeling approach (Q6055651) (← links)
- Robust Approach to Combining Multiple Markers to Improve Surrogacy (Q6079767) (← links)
- Testing for Heterogeneity in the Utility of a Surrogate Marker (Q6079768) (← links)
- Power of testing for exposure effects under incomplete mediation (Q6590286) (← links)
- Assessing heterogeneity in surrogacy using censored data (Q6618309) (← links)
- Quantifying the feasibility of shortening clinical trial duration using surrogate markers (Q6628174) (← links)
- Identifying surrogate markers in real-world comparative effectiveness research (Q6629372) (← links)
